• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会支持是耐多药结核病治疗依从性的关键因素。

Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.

作者信息

Deshmukh R D, Dhande D J, Sachdeva K S, Sreenivas A N, Kumar A M V, Parmar M

机构信息

WHO Country Office for India, New Delhi, India; National AIDS Control Organisation, Ministry of Health and Family Welfare, New Delhi, India.

DR TB Centre NKPS and LMH Nagpur, Maharashtra, India.

出版信息

Indian J Tuberc. 2018 Jan;65(1):41-47. doi: 10.1016/j.ijtb.2017.05.003. Epub 2017 Jun 2.

DOI:10.1016/j.ijtb.2017.05.003
PMID:29332647
Abstract

BACKGROUND

Multidrug-resistant tuberculosis (MDR-TB) is emerging as a major public health problem globally. Treatment success rates in MDR-TB across the globe are not encouraging as completing MDR-TB treatment successfully is challenging due to high proportion of lost to follow up.

METHODS

Using qualitative methods and grounded theory approach, in-depth interviews were conducted with MDR-TB patients and treatment providers. The social cognitive framework was explored as a way to guide understanding of the factors affecting treatment adherence among MDR-TB patients.

RESULTS

Multiple factors influenced patient's decision to adhere to MDR-TB treatment. Self-motivation, awareness about disease and treatment, counselling support, family support, nutritional support and social support were important drivers for successful treatment. Providers related that motivational counselling, nutritional support, family support and social support encouraged treatment adherence.

CONCLUSION

To improve MDR-TB treatment adherence, a patient-centric approach should be considered at the programmatic level. There is a need to formulate strategy that includes motivational counselling, nutritional supplementation and social support mobilisation for treatment adherence. Participants suggested a Patient Support Group led treatment care model for better adherence and treatment success rates in MDR-TB treatment.

摘要

背景

耐多药结核病(MDR-TB)正在成为全球主要的公共卫生问题。由于失访比例高,成功完成耐多药结核病治疗具有挑战性,因此全球耐多药结核病的治疗成功率并不乐观。

方法

采用定性方法和扎根理论方法,对耐多药结核病患者和治疗提供者进行了深入访谈。探索了社会认知框架,作为指导理解影响耐多药结核病患者治疗依从性因素的一种方式。

结果

多种因素影响患者坚持耐多药结核病治疗的决定。自我激励、对疾病和治疗的认识、咨询支持、家庭支持、营养支持和社会支持是成功治疗的重要驱动因素。提供者表示,动机咨询、营养支持、家庭支持和社会支持可鼓励治疗依从性。

结论

为提高耐多药结核病治疗的依从性,应在项目层面考虑以患者为中心的方法。有必要制定一项战略,包括动机咨询、营养补充和动员社会支持以促进治疗依从性。参与者建议采用患者支持小组主导的治疗护理模式,以提高耐多药结核病治疗的依从性和治疗成功率。

相似文献

1
Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.社会支持是耐多药结核病治疗依从性的关键因素。
Indian J Tuberc. 2018 Jan;65(1):41-47. doi: 10.1016/j.ijtb.2017.05.003. Epub 2017 Jun 2.
2
Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.希望所在:一项关于乌兹别克斯坦卡拉卡尔帕克斯坦患者对耐多药结核病治疗依从性的定性研究。
BMC Infect Dis. 2016 Jul 28;16:362. doi: 10.1186/s12879-016-1723-8.
3
The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study.中国耐多药结核病患者的社会支持、治疗中断与治疗结局之间的关系:一项混合方法研究。
Trop Med Int Health. 2018 Jun;23(6):668-677. doi: 10.1111/tmi.13066. Epub 2018 May 16.
4
Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.耐多药结核病治疗药物提醒监测仪在印度两个城市的可接受性:对患者和卫生保健提供者的定性研究。
J Med Internet Res. 2021 Jun 10;23(6):e23294. doi: 10.2196/23294.
5
Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda.乌干达坎帕拉市穆拉戈国家转诊医院耐多药结核病(MDR-TB)治疗不依从的流行情况及相关因素。
Afr Health Sci. 2021 Mar;21(1):238-247. doi: 10.4314/ahs.v21i1.31.
6
Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.患者与医护人员报告的耐多药结核病治疗失访原因:来自印度一家耐药结核病中心的定性研究
PLoS One. 2015 Aug 24;10(8):e0135802. doi: 10.1371/journal.pone.0135802. eCollection 2015.
7
Home based care to multi-drug resistant tuberculosis patients: A pilot study.耐多药结核病患者的居家护理:一项试点研究。
Indian J Tuberc. 2015 Apr;62(2):91-6. doi: 10.1016/j.ijtb.2015.04.008. Epub 2015 Jun 12.
8
Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.移民人群中耐多药结核病治疗依从性:系统评价和荟萃分析。
BMC Med. 2018 Feb 22;16(1):27. doi: 10.1186/s12916-017-1001-7.
9
Implementation fidelity of hospital based directly observed therapy for tuberculosis treatment in Bhutan: mixed-method study.不丹基于医院的直接观察治疗结核病治疗的实施保真度:混合方法研究。
BMC Public Health. 2020 Apr 19;20(1):533. doi: 10.1186/s12889-020-08666-w.
10
Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.耐多药结核病患者中期治疗结果不佳的预测因素。
BMC Infect Dis. 2017 Sep 29;17(1):655. doi: 10.1186/s12879-017-2746-5.

引用本文的文献

1
The effects of stigma and social support on the health-related quality of life of people with drug resistance tuberculosis in Lagos, Nigeria.耻辱感和社会支持对尼日利亚拉各斯耐多药结核病患者健康相关生活质量的影响。
Qual Life Res. 2025 May;34(5):1305-1316. doi: 10.1007/s11136-025-03902-5. Epub 2025 Feb 18.
2
Perceived Social Support and Medication Dose Interruption Among Pulmonary Tuberculosis Patients in Western India: A Cross-Sectional Study.印度西部肺结核患者的感知社会支持与药物剂量中断情况:一项横断面研究
Cureus. 2024 Nov 26;16(11):e74507. doi: 10.7759/cureus.74507. eCollection 2024 Nov.
3
A Mixed-Method Study of Medication-Related Burden Among Multi-Drug Resistant Tuberculosis Patients in West Java, Indonesia.
印度尼西亚西爪哇多药耐药结核病患者药物相关负担的混合方法研究。
Clinicoecon Outcomes Res. 2024 Sep 24;16:707-719. doi: 10.2147/CEOR.S473768. eCollection 2024.
4
Design and prototype of TOMO: an app for improving drug resistant TB treatment adherence.TOMO的设计与原型:一款用于提高耐多药结核病治疗依从性的应用程序
F1000Res. 2021 Sep 29;10:983. doi: 10.12688/f1000research.67212.1. eCollection 2021.
5
Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea.韩国新诊断肺结核患者免费用药政策对治疗中断的影响。
Int J Health Policy Manag. 2024;13:8262. doi: 10.34172/ijhpm.8262. Epub 2024 Jul 14.
6
Perceived access to social support during and after TB treatment in Mbeya and Songwe regions, Tanzania: perspectives from TB patients and survivors set against health care providers.坦桑尼亚姆贝亚和松圭地区结核病治疗期间及之后获得社会支持的感知情况:结核病患者和幸存者与医疗服务提供者的观点对比
Front Health Serv. 2024 Jul 11;4:1273739. doi: 10.3389/frhs.2024.1273739. eCollection 2024.
7
Interaction of social support and depressive symptoms on antiretroviral therapy adherence among people living with HIV in South Africa.社会支持与抑郁症状对南非艾滋病病毒感染者抗逆转录病毒治疗依从性的相互作用。
Health SA. 2024 Jun 6;29:2271. doi: 10.4102/hsag.v29i0.2271. eCollection 2024.
8
Exploring health care providers' engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study.探讨哈迪耶地区医疗保健机构中医疗保健提供者参与耐多药结核病的预防和管理及其影响因素:定性研究。
BMC Health Serv Res. 2024 Apr 27;24(1):542. doi: 10.1186/s12913-024-10911-6.
9
Factors Associated with Non-Adherence to Treatment Among Migrants with MDR-TB in Wuhan, China: A Cross-Sectional Study.中国武汉耐多药结核病移民中与治疗不依从相关的因素:一项横断面研究
Risk Manag Healthc Policy. 2024 Mar 26;17:727-737. doi: 10.2147/RMHP.S448706. eCollection 2024.
10
Lived experiences of patients and families with decentralised drug-resistant tuberculosis care in the Eastern Cape, South Africa.南非东开普省接受去中心化耐药结核病护理的患者及其家庭的生活体验。
Afr J Prim Health Care Fam Med. 2023 Dec 22;15(1):e1-e16. doi: 10.4102/phcfm.v15i1.4255.